Mumbai, July 24 -- Revenue from operations rose 24.34% year-on-year (YoY) to Rs 240.02 crore, driven by sustained momentum in the pathology segment.

Profit before tax (PBT) increased 35.28% YoY to Rs 68.29 crore in the quarter ended 30th June 2026.

EBITDA grew 34% YoY to Rs 77.27 crore, while the EBITDA margin improved to 32.2% in Q1 FY27 from 29.9% in Q1 FY26, reflecting improved operating efficiency.

The pathology segment registered a 26% YoY growth in revenue to Rs 225.6 crore. Within the segment, franchise revenue increased 27% to Rs 142.8 crore, while partnership revenue rose 26% compared with the year-ago period.

Operationally, the company processed 55.2 million diagnostic tests during the quarter, up 28% YoY. Revenue per test s...